Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal.
Identifieur interne : 000419 ( Main/Exploration ); précédent : 000418; suivant : 000420Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal.
Auteurs : Adrian Wong [États-Unis] ; Neal J. Benedict [États-Unis] ; Sandra L. Kane-Gill [États-Unis]Source :
- Journal of critical care [ 1557-8615 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Benzodiazépines (usage thérapeutique), Crises épileptiques du sevrage alcoolique (traitement médicamenteux), Crises épileptiques du sevrage alcoolique (épidémiologie), Dexmédétomidine (usage thérapeutique), Durée du séjour, Délirium trémens (traitement médicamenteux), Délirium trémens (épidémiologie), Femelle, Humains, Hypnotiques et sédatifs (usage thérapeutique), Infection croisée (épidémiologie), Mâle, Neuroleptiques (usage thérapeutique), Pneumopathie infectieuse (épidémiologie), Propofol (usage thérapeutique), Unités de soins intensifs, Ventilation artificielle (), Études rétrospectives.
- MESH :
- traitement médicamenteux : Crises épileptiques du sevrage alcoolique, Délirium trémens.
- usage thérapeutique : Benzodiazépines, Dexmédétomidine, Hypnotiques et sédatifs, Neuroleptiques, Propofol.
- épidémiologie : Crises épileptiques du sevrage alcoolique, Délirium trémens, Infection croisée, Pneumopathie infectieuse.
- Adulte, Adulte d'âge moyen, Durée du séjour, Femelle, Humains, Mâle, Unités de soins intensifs, Ventilation artificielle, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Alcohol Withdrawal Delirium (drug therapy), Alcohol Withdrawal Delirium (epidemiology), Alcohol Withdrawal Seizures (drug therapy), Alcohol Withdrawal Seizures (epidemiology), Antipsychotic Agents (therapeutic use), Benzodiazepines (therapeutic use), Cross Infection (epidemiology), Dexmedetomidine (therapeutic use), Female, Humans, Hypnotics and Sedatives (therapeutic use), Intensive Care Units, Length of Stay, Male, Middle Aged, Pneumonia (epidemiology), Propofol (therapeutic use), Respiration, Artificial (statistics & numerical data), Retrospective Studies.
- MESH :
- chemical , therapeutic use : Antipsychotic Agents, Benzodiazepines, Dexmedetomidine, Hypnotics and Sedatives, Propofol.
- drug therapy : Alcohol Withdrawal Delirium, Alcohol Withdrawal Seizures.
- epidemiology : Alcohol Withdrawal Delirium, Alcohol Withdrawal Seizures, Cross Infection, Pneumonia.
- statistics & numerical data : Respiration, Artificial.
- Adult, Female, Humans, Intensive Care Units, Length of Stay, Male, Middle Aged, Retrospective Studies.
Abstract
A subset of patients with alcohol withdrawal syndrome does not respond to benzodiazepine treatment despite escalating doses. Resistant alcohol withdrawal (RAW) is associated with higher incidences of mechanical ventilation and nosocomial pneumonia and longer intensive care unit (ICU) stay. The objective of this study is to characterize pharmacologic management of RAW and outcomes.
DOI: 10.1016/j.jcrc.2014.10.008
PubMed: 25433725
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000394
- to stream PubMed, to step Curation: 000394
- to stream PubMed, to step Checkpoint: 000394
- to stream Ncbi, to step Merge: 004012
- to stream Ncbi, to step Curation: 004012
- to stream Ncbi, to step Checkpoint: 004012
- to stream Main, to step Merge: 000419
- to stream Main, to step Curation: 000419
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal.</title>
<author><name sortKey="Wong, Adrian" sort="Wong, Adrian" uniqKey="Wong A" first="Adrian" last="Wong">Adrian Wong</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Benedict, Neal J" sort="Benedict, Neal J" uniqKey="Benedict N" first="Neal J" last="Benedict">Neal J. Benedict</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA. Electronic address: benedictnj@upmc.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kane Gill, Sandra L" sort="Kane Gill, Sandra L" uniqKey="Kane Gill S" first="Sandra L" last="Kane-Gill">Sandra L. Kane-Gill</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25433725</idno>
<idno type="pmid">25433725</idno>
<idno type="doi">10.1016/j.jcrc.2014.10.008</idno>
<idno type="wicri:Area/PubMed/Corpus">000394</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000394</idno>
<idno type="wicri:Area/PubMed/Curation">000394</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000394</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000394</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000394</idno>
<idno type="wicri:Area/Ncbi/Merge">004012</idno>
<idno type="wicri:Area/Ncbi/Curation">004012</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004012</idno>
<idno type="wicri:Area/Main/Merge">000419</idno>
<idno type="wicri:Area/Main/Curation">000419</idno>
<idno type="wicri:Area/Main/Exploration">000419</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal.</title>
<author><name sortKey="Wong, Adrian" sort="Wong, Adrian" uniqKey="Wong A" first="Adrian" last="Wong">Adrian Wong</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Benedict, Neal J" sort="Benedict, Neal J" uniqKey="Benedict N" first="Neal J" last="Benedict">Neal J. Benedict</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA. Electronic address: benedictnj@upmc.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kane Gill, Sandra L" sort="Kane Gill, Sandra L" uniqKey="Kane Gill S" first="Sandra L" last="Kane-Gill">Sandra L. Kane-Gill</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacy, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of critical care</title>
<idno type="eISSN">1557-8615</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Alcohol Withdrawal Delirium (drug therapy)</term>
<term>Alcohol Withdrawal Delirium (epidemiology)</term>
<term>Alcohol Withdrawal Seizures (drug therapy)</term>
<term>Alcohol Withdrawal Seizures (epidemiology)</term>
<term>Antipsychotic Agents (therapeutic use)</term>
<term>Benzodiazepines (therapeutic use)</term>
<term>Cross Infection (epidemiology)</term>
<term>Dexmedetomidine (therapeutic use)</term>
<term>Female</term>
<term>Humans</term>
<term>Hypnotics and Sedatives (therapeutic use)</term>
<term>Intensive Care Units</term>
<term>Length of Stay</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pneumonia (epidemiology)</term>
<term>Propofol (therapeutic use)</term>
<term>Respiration, Artificial (statistics & numerical data)</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Benzodiazépines (usage thérapeutique)</term>
<term>Crises épileptiques du sevrage alcoolique (traitement médicamenteux)</term>
<term>Crises épileptiques du sevrage alcoolique (épidémiologie)</term>
<term>Dexmédétomidine (usage thérapeutique)</term>
<term>Durée du séjour</term>
<term>Délirium trémens (traitement médicamenteux)</term>
<term>Délirium trémens (épidémiologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hypnotiques et sédatifs (usage thérapeutique)</term>
<term>Infection croisée (épidémiologie)</term>
<term>Mâle</term>
<term>Neuroleptiques (usage thérapeutique)</term>
<term>Pneumopathie infectieuse (épidémiologie)</term>
<term>Propofol (usage thérapeutique)</term>
<term>Unités de soins intensifs</term>
<term>Ventilation artificielle ()</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Benzodiazepines</term>
<term>Dexmedetomidine</term>
<term>Hypnotics and Sedatives</term>
<term>Propofol</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Alcohol Withdrawal Delirium</term>
<term>Alcohol Withdrawal Seizures</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Alcohol Withdrawal Delirium</term>
<term>Alcohol Withdrawal Seizures</term>
<term>Cross Infection</term>
<term>Pneumonia</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Respiration, Artificial</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Crises épileptiques du sevrage alcoolique</term>
<term>Délirium trémens</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Benzodiazépines</term>
<term>Dexmédétomidine</term>
<term>Hypnotiques et sédatifs</term>
<term>Neuroleptiques</term>
<term>Propofol</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Crises épileptiques du sevrage alcoolique</term>
<term>Délirium trémens</term>
<term>Infection croisée</term>
<term>Pneumopathie infectieuse</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Intensive Care Units</term>
<term>Length of Stay</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Durée du séjour</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Unités de soins intensifs</term>
<term>Ventilation artificielle</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A subset of patients with alcohol withdrawal syndrome does not respond to benzodiazepine treatment despite escalating doses. Resistant alcohol withdrawal (RAW) is associated with higher incidences of mechanical ventilation and nosocomial pneumonia and longer intensive care unit (ICU) stay. The objective of this study is to characterize pharmacologic management of RAW and outcomes.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Pennsylvanie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Wong, Adrian" sort="Wong, Adrian" uniqKey="Wong A" first="Adrian" last="Wong">Adrian Wong</name>
</region>
<name sortKey="Benedict, Neal J" sort="Benedict, Neal J" uniqKey="Benedict N" first="Neal J" last="Benedict">Neal J. Benedict</name>
<name sortKey="Kane Gill, Sandra L" sort="Kane Gill, Sandra L" uniqKey="Kane Gill S" first="Sandra L" last="Kane-Gill">Sandra L. Kane-Gill</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000419 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000419 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Amérique |area= PittsburghV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:25433725 |texte= Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25433725" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a PittsburghV1
This area was generated with Dilib version V0.6.38. |